Medikamentöse Therapie 5 - Deutsche Gesellschaft für ...

340
z 5.5 Therapieempfehlungen zu speziellen Krankheitsbildern
14. Groothoff JW, van Leeuwen EF (1988) High dose intravenous gammaglobulin in
chronic systemic juvenile arthritis. Br Med J 296:1362–1363
15. Halle F, Prieur AM (1991) Evaluation of methotrexate in the treatment of juvenile
chronic arthritis according to the subtype. Clin Exp Rheumatol 9:297–302
16. Häfner R (2002) Juvenile idiopathische Arthritis. Die neue Nomenklatur und
Klassifikation der chronischen Arthritis im Kindesalter. Akt Rheumatol 27:18–21
17. Häfner R, Spamer M (1998) Rehabilitation of children. In: Maddison PJ, Isenberg
Da, Woo P, Glass DN (eds) Oxford Textbook of Rheumatology. Oxford University
Press, Oxford, pp 1737–1755
18. Häfner R, Truckenbrodt H, Michels H, von Altenbockum C (1991) Therapie der
juvenilen chronischen Arthritis. Dt Ärzteblatt 88:2402–2407
19. Horneff G, Forster J, Seyberth HW, Michels H, für die Arbeitsgemeinschaft Kinderund
Jugendrheumatologie (2000) Empfehlungen der Arbeitsgemeinschaft Kinderund
Jugendrheumatologie zur Therapie mit Etanercept (P75 TNF-alpha-Rezeptor-
Immunglobulinfusionsprotein). Kommission Pharmakotherapie. Z Rheumatol 59:
365–369
20. Huppertz HI, Tschammier A, Horwitz A, Schwab O (1995) Intraarticular corticosteroids
for chronic arthritis in children: efficacy and effects on cartilage and
growth. J Pediatr 127:317–321
21. Jung JH, Jun JB, Yoo DH, Kim TH, Jung SS, Lee IH, Bae SC, Kim SY (2000) High
toxicity of sulfasalazine in adult-onset Still’s disease. Clin Exp Rheumatol 18:
245–248
22. Kilmartin DJ, Forrester JV, Dick AD (1998) Cyclosporin A therapy in refractory
non-infectious childhood uveitis. Br J Ophthalmol 82:737–742
23. Krugmann J, Sailer-Hock M, Muller T, Gruber J, Allerberger F, Offner FA (2000)
Epstein-Barr virus-associated Hodgkin’s lymphoma and legionella pneumophila
infection complicating treatment of juvenile rheumatoid arthritis with methotrexate
and cyclosporine A. Hum Pathol 31:253–255
24. Kvien TK, Hoyeraal HM, Sandstad B (1986) Azathioprine versus placebo in patients
with juvenile rheumatoid arthritis: a single center double blind comparative
study. J Rheumatol 13:118–123
25. Lahdenne P, Honkanen V (2000) Infiximab vs. etanercept in the treatment of
severe juvenile chronic arthritis (JCA). Arthritis Rheum 43(suppl):S 381
26. Lehmann TJA (1993) Aggressive therapy for childhood rheumatic diseases. When
are immunosuppressives appropriate? Arthritis Rheum 36:71–74
28. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein
LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK (2000) Etanercept
in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:
763–769
29. Michels H (1997) Is there a renaissance of corticosteroid therapy? Rev Rhum
64:183S–185S
30. Michels H (2000) What is low-dose corticosteroid therapy in juvenile idiopathic
arthritis? Z Rheumatol 59 (suppl 2):II/127–II/130
31. Michels H, Truckenbrodt H (1987) Improved prognosis for iridocyclitis in juvenile
chronic arthritis. Clin Exp Rheum 5 (suppl):20
32. Miller III JJ (1980) Prolonged use of large intravenous steroid pulses in the rheumatic
diseases of children. Pediatrics 65:989–994
33. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM (1996) Efficacy of
cyclosporine A in the treatment of macrophage activation syndrome in juvenile
arthritis: report of five cases. J Pediatr 129:750–754